Table 3

Multivariate analysis of associations of patient, tumor, treatment, and pathologic characteristics with survival

VariableTime to failure survivalOverall survival
HR95% CIP valueHR95% CIP value
TNM stage1.3930.59–3.2890.4490.1250.006–2.3840.350
IORT dose ≤ 15 (vs. > 15)0.3890.139–2.1570.5472.1200.473–9.5090.326
D-dimer < 500 (vs. ≥ 500)0.2190.070–0.6820.009*0.2300.070–0.7630.016*
CEA < 5 (vs. ≥ 5)0.3840.159–0.9280.034*0.2810.109–0.7250.009*
CA19-9 < 37 (vs. ≥ 37)0.6660.282–1.5690.3520.2340.079–0.6920.009*
  • *P < 0.05 was considered statistically significant. HR, hazard ratio; CI, confidence interval.